{
    "clinical_study": {
        "@rank": "80736", 
        "arm_group": {
            "arm_group_label": "Microdose", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "This study aims to determine the absolute bioavailability of YH4808 using simultaneous oral\n      therapeutic- and [14C]-labeled intravenous microdoses."
        }, 
        "brief_title": "Absolute Bioavailability of YH4808 With Accelerator Mass Spectrometry(AMS)-Based Microdose Study", 
        "completion_date": {
            "#text": "April 2014", 
            "@type": "Actual"
        }, 
        "condition": "Gastroesophageal Reflux Disease", 
        "condition_browse": {
            "mesh_term": "Gastroesophageal Reflux"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  healthy male subject aged 20 to 45 at screening\n\n          -  subjects who have weight over 55 kg with BMI ranged from 20.0 to 25.0\n\n          -  subjects who decide to participate voluntarily and write a informed consent form\n\n        Exclusion Criteria:\n\n          -  subjects who have clinically significant disease of cardiovascular, respiratory,\n             renal, endocrinological, hematological, gastrointestinal, neurological(central\n             nervous system), psychiatric disorders or malignant tumor\n\n          -  clinically significant allergic disease (except for mild allergic rhinitis)\n\n          -  subjects who have determined not eligible by screening test (medical history,\n             physical examination, 12-lead ECG, laboratory test, etc) within 28 days of study\n             start\n\n          -  subjects considered unsuitable for inclusion by the investigator"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "45 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "8", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "February 21, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02072447", 
            "org_study_id": "Microdose_01(YH4808-110(I))"
        }, 
        "intervention": {
            "arm_group_label": "Microdose", 
            "intervention_name": "YH4808 PO and [14C]-YH4808 IV", 
            "intervention_type": "Drug"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "absolute bioavailability,", 
            "microdose,", 
            "AMS"
        ], 
        "lastchanged_date": "April 17, 2014", 
        "link": {
            "description": "Webpage of clinical trial center of Seoul National University Hospital", 
            "url": "http://ctc.snuh.org"
        }, 
        "location": {
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of"
                }, 
                "name": "Seoul National University Hospital"
            }
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "1", 
        "official_title": "A Study to Determine the Absolute Bioavailability of YH4808 Using Simultaneous Oral Therapeutic- and [14C]-Labeled Intravenous Microdoses", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Korea: Food and Drug Administration"
        }, 
        "phase": "Phase 0", 
        "primary_completion_date": {
            "#text": "April 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Absolute bioavailability (Fpo)", 
            "safety_issue": "Yes", 
            "time_frame": "predose, 0.25, 0.5, 0.75, 1, 1.25, 1.5, 1.75, 2, 2.5, 3, 3.5, 4, 5, 6, 7, 8, 9, 12, 13, 24, 48, 96, 144, 216 hours post-dose"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02072447"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Seoul National University Hospital", 
            "investigator_full_name": "Howard Lee", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Seoul National University Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Seoul National University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2014", 
        "study_design": "Endpoint Classification: Bio-availability Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}